Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|April 19, 2023
Fluorescein Angiography Findings in Susac Syndrome: A Multicenter Retrospective Case SeriesDevon A Cohen, Deena Tajfirouz, Ivana Vodopivec, et al.
Nature Communications|November 18, 2023
Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myelomaRebecca C Larson, Michael C Kann, Charlotte Graham, et al.
Journal for Immunotherapy of Cancer|September 10, 2025
Tandem CAR-T cells targeting mesothelin and MUC16 overcome tumor heterogeneity by targeting one antigen at a timeDiego Salas-Benito, Filippo Birocchi, Sangwoo Park, et al.
Cell Chemical Biology|November 21, 2023
Genetic retargeting of E3 ligases to enhance CAR T cell therapyIsabel C Lane, Gabriele Kembuan, Jeannie Carreiro, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastomaBryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Journal for Immunotherapy of Cancer|September 9, 2020
Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sourcesAndrea Schmidts, Leah C Marsh, Ambike A Srivastava, et al.
Nature|April 14, 2022
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumoursRebecca C Larson, Michael C Kann, Stefanie R Bailey, et al.
Science Translational Medicine|January 7, 2021
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomideMax Jan, Irene Scarfò, Rebecca C Larson, et al.
Nature Biotechnology|July 24, 2019
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicityBryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Pageof 13